JNBA Financial Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.27M Sell
9,004
-18
-0.2% -$3.87K 0.17% 64
2026
Q1
$1.96M Sell
9,022
-179
-2% -$39.7K 0.16% 67
2025
Q4
$2.1M Sell
9,201
-172
-2% -$39.2K 0.18% 62
2025
Q3
$2.17M Buy
9,373
+77
+0.8% +$15.7K 0.2% 62
2025
Q2
$1.73M Hold
9,296
0.17% 68
2025
Q1
$1.95M Buy
9,296
+225
+2% +$43.7K 0.2% 59
2024
Q4
$1.61M Sell
9,071
-26
-0.3% -$4.78K 0.16% 68
2024
Q3
$1.8M Hold
9,097
0.18% 62
2024
Q2
$1.56M Buy
9,097
+120
+1% +$19.9K 0.16% 70
2024
Q1
$1.63M Sell
8,977
-231
-3% -$39.8K 0.17% 73
2023
Q4
$1.43M Buy
9,208
+66
+0.7% +$9.62K 0.16% 83
2023
Q3
$1.36M Sell
9,142
-235
-3% -$34.5K 0.17% 79
2023
Q2
$1.26M Buy
9,377
+30
+0.3% +$4.4K 0.15% 84
2023
Q1
$1.49M Sell
9,347
-376
-4% -$57.5K 0.19% 77
2022
Q4
$1.57M Sell
9,723
-319
-3% -$48.9K 0.22% 71
2022
Q3
$1.35M Sell
10,042
-162
-2% -$23.2K 0.21% 75
2022
Q2
$1.56M Buy
10,204
+71
+0.7% +$10.8K 0.24% 68
2022
Q1
$1.64M Sell
10,133
-563
-5% -$81.8K 0.22% 70
2021
Q4
$1.45M Sell
10,696
-165
-2% -$19.5K 0.18% 78
2021
Q3
$1.17M Hold
10,861
0.16% 85
2021
Q2
$1.22M Hold
10,861
0.17% 82
2021
Q1
$1.18M Buy
10,861
+256
+2% +$27.4K 0.17% 79
2020
Q4
$1.14M Buy
10,605
+44
+0.4% +$4.23K 0.19% 76
2020
Q3
$925K Sell
10,561
-50
-0.5% -$4.71K 0.19% 78
2020
Q2
$1.04M Buy
10,611
+37
+0.3% +$3.26K 0.22% 72
2020
Q1
$806K Buy
10,574
+310
+3% +$26.4K 0.19% 77
2019
Q4
$909K Hold
10,264
0.17% 81
2019
Q3
$777K Sell
10,264
-290
-3% -$19.9K 0.16% 81
2019
Q2
$768K Buy
10,554
+293
+3% +$23K 0.16% 80
2019
Q1
$827K Sell
10,261
-51
-0.5% -$4.17K 0.18% 73
2018
Q4
$951K Buy
10,312
+260
+3% +$22.9K 0.22% 59
2018
Q3
$951K Sell
10,052
-123
-1% -$11.7K 0.43% 56
2018
Q2
$943K Hold
10,175
0.2% 56
2018
Q1
$963K Sell
10,175
-100
-1% -$11K 0.21% 54
2017
Q4
$994K Sell
10,275
-570
-5% -$53.7K 0.21% 53
2017
Q3
$964K Sell
10,845
-1,526
-12% -$116K 0.22% 49
2017
Q2
$897K Buy
12,371
+2
+0% +$134 0.2% 49
2017
Q1
$806K Buy
12,369
+2
+0% +$126 0.19% 56
2016
Q4
$774K Buy
12,367
+2,628
+27% +$160K 0.19% 54
2016
Q3
$614K Sell
9,739
-2,233
-19% -$145K 0.09% 80
2016
Q2
$741K Buy
11,972
+200
+2% +$12.2K 0.21% 49
2016
Q1
$672K Hold
11,772
0.24% 50
2015
Q4
$697K Buy
11,772
+980
+9% +$56.4K 0.27% 44
2015
Q3
$587K Buy
10,792
+1,495
+16% +$97.3K 0.25% 44
2015
Q2
$625K Hold
9,297
0.24% 45
2015
Q1
$544K Hold
9,297
0.21% 48
2014
Q4
$608K Sell
9,297
-150
-2% -$9.46K 0.25% 46
2014
Q3
$546K Buy
9,447
+365
+4% +$20.3K 0.25% 48
2014
Q2
$513K Hold
9,082
0.25% 51
2014
Q1
$467K Sell
9,082
-1,330
-13% -$67.2K 0.25% 52
2013
Q4
$550K Buy
10,412
+581
+6% +$28.6K 0.3% 45
2013
Q3
$440K Sell
9,831
-2,092
-18% -$92.7K 0.27% 54
2013
Q2
$493K Buy
+11,923
New +$521K 0.34% 44

Other funds holding ABBV

JNBA Financial Advisors's ABBV Position: Q2 2026 in Review

JNBA Financial Advisors reduced its AbbVie (ABBV) stake by 0.2% in Q2 2026, selling an estimated $3.87K and leaving 9,004 shares worth $2.27M. The position accounts for 0.17% of the portfolio, ranked #64.

JNBA Financial Advisors first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. 1,576 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • JNBA Financial Advisors held 9,004 shares of AbbVie worth $2.27M as of Q2 2026.
  • JNBA Financial Advisors sold 18 AbbVie shares in Q2 2026, an estimated $3.87K.
  • AbbVie made up 0.17% of JNBA Financial Advisors's portfolio in Q2 2026, its #64 holding.
  • JNBA Financial Advisors first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • 1,576 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on JNBA Financial Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.